title: [Prevention of post-surgical recurrence of Crohn's disease. A perspective].
abstract: Crohn's disease often leads to stricture formation, occlusion and surgery. Unfortunately the disease tends to recur often. Traditional medications seem very little effective for recurrence prevention. By contrast, biologics appear extremely promising and potentially capable of changing radically the management of this disease.
authors.affiliation: Cattedre di Gastroenterologia, Chirurgia Digestiva, Anatomia Patologica e Radiologia, Università, Udine.
authors.forename: Alberto
authors.initials: A
authors.lastname: Paviotti
authors.forename: Giovanni
authors.initials: G
authors.lastname: Terrosu
authors.forename: Claudio
authors.initials: C
authors.lastname: Avellini
authors.forename: Rossano
authors.initials: R
authors.lastname: Girometti
authors.forename: Dario
authors.initials: D
authors.lastname: Sorrentino
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy / Q000517:prevention & control* / Q000601:surgery; D013505:Digestive System Surgical Procedures; D004359:Drug Therapy, Combination; D005544:Forecasting; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000069285:Infliximab; D016753:Interleukin-10 / Q000008:administration & dosage / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D055502:Secondary Prevention
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D016753:Interleukin-10; D000069285:Infliximab